The chartered accountant and registered tax agent has more than 30 years of senior and board level experience across publicly listed companies serving at CFO, director and company secretary.
Admedus’s chairman John Seaberg said: “We are very pleased to welcome Steve to the Admedus board.
“His comprehensive experience in financial management and deep understanding of the Australian and global financial regulatory environments make him a valuable addition to the company’s leadership as we pursue exciting new strategic opportunities.”
Substantial investor, Star Bright Holding Ltd and its associated companies recently increased its shareholding to 19.99%.
The ownership is a result of participation in 2018 capital raisings which came in the form of share placements.
Admedus is also negotiating with Star Bright in respect of a long-term funding agreement for Admedus Immunotherapies.
The two parties entered a memorandum of understanding (MoU) for a 60% share of the vaccines business for an initial investment of $18 million.